Phase II trial of Liposomal Grb-2 (BP 100-1-01) combination salvage therapy in patients with chronic myeloid leukaemia

Trial Profile

Phase II trial of Liposomal Grb-2 (BP 100-1-01) combination salvage therapy in patients with chronic myeloid leukaemia

Planning
Phase of Trial: Phase II

Latest Information Update: 16 Mar 2016

At a glance

  • Drugs Prexigebersen (Primary) ; Antineoplastics
  • Indications Chronic myeloid leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Bio-Path Holdings
  • Most Recent Events

    • 16 Mar 2016 According to Bio-Path Holdings media release, this trial expected to start in the second quarter of 2016.
    • 16 Mar 2016 Planned initiation date changed from 31 Dec 2015 to 1 Apr 2016, as reported by Bio-Path Holdings media release.
    • 21 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top